Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue

被引：16

作者：

Barry, A

Bille, J

Brown, S

Ellis, D

Meis, J

Pfaller, M

Rennie, R

Rinaldi, M

Rogers, T

Traczewski, M

机构：

[1] Inst Clin Microbiol, Wilsonville, OR 97070 USA

[2] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland

[3] Womens & Childrens Hosp, Adelaide, SA, Australia

[4] Canisius Wilhelmina Hosp, Ctr Infect Dis, Nijmegen, Netherlands

[5] Univ Iowa, Iowa City, IA USA

[6] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada

[7] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA

[8] Univ London Imperial Coll Sci Technol & Med, London, England

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2003年 / 41卷 / 07期

关键词：

D O I：

10.1128/JCM.41.7.3410-3412.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

An international collaborative study was performed in order to propose quality control limits for fluconazole disk diffusion susceptibility tests on Mueller-Hinton agar with 2% glucose and 0.5 mug of methylene blue per ml. The supplements may be added before autoclaving the agar, or Mueller-Hinton agar plates may be Hooded with a glucos-methylene blue solution. Replicate tests on both types of agar plates generated data to propose zone size limits for tests of Candida parapsilosis ATCC 22019 (22 to 33 mm), C. tropicalis ATCC 750 (26 to 37 mm), and C. albicans ATCC 90028 (28 to 39 mm). C. krusei ATCC 6258 was not useful for this purpose.

引用

页码：3410 / 3412

页数：3

共 9 条

[1] Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods
Barry, AL
Pfaller, MA
Rennie, RP
Fuchs, PC
Brown, SD
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1781 - 1784
[2] Fluconazole disk diffusion procedure for determining susceptibility of Candida species
Barry, AL
Brown, SD
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) : 2154 - 2157
[3] When should Candida isolates be tested for susceptibility to azole antifungal agents?
Bille, J
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (04) : 281 - 282
[4] DEVELOPMENT OF RESISTANCE IN CANDIDA ISOLATES FROM PATIENTS RECEIVING PROLONGED ANTIFUNGAL THERAPY
FANHAVARD, P
CAPANO, D
SMITH, SM
MANGIA, A
ENG, RHK
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2302 - 2305
[5] QUALITY-CONTROL LIMITS FOR AMPICILLIN, CARBENICILLIN, MEZLOCILLIN, AND PIPERACILLIN DISK DIFFUSION SUSCEPTIBILITY TESTS - A COLLABORATIVE STUDY
GAVAN, TL
JONES, RN
BARRY, AL
FUCHS, PC
GERLACH, EH
MATSEN, JM
RELLER, LB
THORNSBERRY, C
THRUPP, LD
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1981, 14 (01) : 67 - 72
[6] Fluconazole disk diffusion susceptibility testing of Candida species
Kirkpatrick, WR
Turner, TM
Fothergill, AW
McCarthy, DI
Redding, SW
Rinaldi, MG
Patterson, TF
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) : 3429 - 3432
[7] Fluconazole disc diffusion testing for the routine laboratory
May, JL
King, A
Warren, CA
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) : 511 - 516
[8] A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion
Meis, J
Petrou, M
Bille, J
Ellis, D
Gibbs, D
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (04) : 215 - 223
[9] Detection of fluconazole-resistant Candida strains by a disc diffusion screening test
Sandven, P
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) : 3856 - 3859

← 1 →